American Society of Hirudotherapy

Effectiveness of leech therapy in women with symptomatic arthrosis of the first carpometacarpal joint: a randomized controlled trial

Michalsen A, Lüdtke R, Cesur Ö, Afra D, Musial F, Baecker M, Fink M, Dobos GJ (2008) · Pain · n=32

RCT evidence detailTrial reference
Sample size of this trial compared with other Thumb Carpometacarpal (CMC-1) Osteoarthritis trialsMichalsen A 200832Spaans AJ 201523
This trial (highlighted) by sample size alongside other indexed Thumb Carpometacarpal (CMC-1) Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
randomized controlled trial (Kliniken Essen-Mitte, Essen, Germany)
Sample size (n)
32
Intervention
Single treatment with 2-3 locally applied leeches (n=16)
Comparator
Topical diclofenac twice daily for 30 days (n=16)
Primary endpoint
Change in overall pain (mean VAS at rest, in motion and during grip) from baseline to day 7
Primary result
Overall pain at day 7 fell from 59.6 to 27.1 mm with leeches and from 50.6 to 46.9 mm with diclofenac (group difference -26.5 mm, 95% CI -40.3 to -12.7; p=0.0003); differences favouring leeches increased at days 30 and 60.
Follow-up duration
60 days

Key Findings

  • Overall pain at day 7: 59.6 to 27.1 mm with leeches vs 50.6 to 46.9 mm with diclofenac (difference -26.5 mm, p=0.0003)
  • The difference in pain relief favouring leeches increased at days 30 and 60
  • Disability (DASH), quality of life (SF-36) and grip strength also improved significantly
  • Results were not affected by outcome expectation or use of analgesics

Limitations

  • Small sample (32 women)
  • Women only
  • Follow-up limited to 60 days

Clinical Implications

A single course of leech therapy relieved pain and improved disability and quality of life for at least two months in thumb-base osteoarthritis, compared with topical diclofenac. The authors call for further study of leech therapy for arthritic pain and of its mechanisms.

Related Trials

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.